Goodwill Pharma Plc Logo

Goodwill Pharma Plc

Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.

GWPH | BUD

Overview

Corporate Details

ISIN(s):
HU0000199575
LEI:
Country:
Hungary
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Goodwill Pharma Plc is a fully integrated pharmaceutical company specializing in the development, manufacturing, and distribution of therapeutic products. Its portfolio includes prescription (Rx) and over-the-counter (OTC) medications, food supplements, and medical devices. Primarily serving the Central and Eastern European (CEE) markets, the company is expanding its international presence through strategic partnerships and exports. As a full-service Contract Development and Manufacturing Organization (CDMO), Goodwill Pharma provides comprehensive solutions across the entire product lifecycle, from research and development in collaboration with academic institutions to large-scale commercial manufacturing, regulatory affairs, logistics, and marketing support. The company focuses on making high-quality, innovative, and accessible healthcare products available to patients and healthcare professionals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 17:43
Notice of Dividend Amount
Tájékoztatás osztalékfizetésről
Hungarian 136.6 KB
2025-10-31 10:39
Declaration of Voting Results & Voting Rights Announcements
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 153.7 KB
2025-10-01 09:03
Declaration of Voting Results & Voting Rights Announcements
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 153.8 KB
2025-09-30 09:12
Interim Report
2025 I. féléves konszolidált tőzsdei jelentés
Hungarian 937.0 KB
2025-09-01 10:57
Declaration of Voting Results & Voting Rights Announcements
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 153.3 KB
2025-08-25 10:06
Notice of Dividend Amount
Osztalékfizetés
Hungarian 137.4 KB
2025-08-01 09:49
Share Issue/Capital Change
Tájékoztatás alaptőkéről és szavazati jogokról
Hungarian 153.4 KB
2025-07-21 13:20
Notice of Dividend Amount
Osztalékfizetés
Hungarian 136.6 KB

Automate Your Workflow. Get a real-time feed of all Goodwill Pharma Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Goodwill Pharma Plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Goodwill Pharma Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.